Some of the names on the move ahead of the open.
Academy Sports + Outdoors and Dick's Sporting Goods have expressed interest in buying the assets of rival U.S. retailer Sports Authority.
Yahoo's web business is estimated to be worth several billion of dollars more than Time Inc's market capitalization of just $1.6 billion.
Jim Cramer gives his opinion on caller stocks at rapid speed, including this pharmaceutical company that could be a real dice roll this year.
Discussing evidence of fear still exists in the market, and where we go from here, with CNBC contributor Ron Insana, and Jeff Kilburg, KKM Financial.
Fintech start-ups' fundings took off in 2015, with corporate investors and banks looking to get in on the action.
There are several signs we are seeing somewhat more aggressive buyback announcements than usual.
U.S. stock index futures indicated a sharply lower open on Thursday.
Jim Cramer shares his opinion for caller favorite stocks, including this popular retail play.
Ariel Investments' Charley Bobrinskoy and Societe Generale's Larry McDonald debate a turnaround in financials.
Private equity is disappointing analysts, buying fewer companies and making less exits.
Eaton Vance portfolio manager Yana Barton and Brandywine Global portfolio manager Patrick Kaser share what they think are best growth and value plays for investors.
Banks' loans are costing them more as defaults are on the rise in the U.S.
Banks trading beneath tangible book value could become targeted by activist investors.
In a sector plagued by government scrutiny in the U.S., one major for-profit education company has found a way to circumvent regulation.
John Rogers Jr., chairman of Ariel Investments, bought shares of a provider of aerial transportation services for CNBC Pro's Platinum Portfolio.
Dealmaking in America's oil patch has slowed to a trickle, while organized restructurings have ticked up among drillers.
Buyout firms KKR, Thoma Bravo, and Vista Equity Partners Management are competing for Dell's assets, people familiar with the matter said.
Jim Cramer gives his opinion on various caller favorite stocks, including this hated biotech play.
China International Capital Corp got off to a strong start, as its HKEx debut coincided with Beijing's decision to lift a four-month IPO ban.